Since then, DSRLF stock has increased by 77.0% and is now trading at $216.80. Kepler Capital Markets upgraded shares of DiaSorin (OTCMKTS:DSRLF) from a hold rating to a buy rating in a research note issued to investors on Thursday morning, The Fly reports. MarketBeat just released five new trading ideas, but DiaSorin wasn't one of them. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. See what's happening in the market right now with MarketBeat's real-time news feed. DiaSorin Molecular branches are located throughout the world and are organized by country for your convenience. 17 Sep 2020. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. Read the press release. The company offers testing kits for … Diasorin says acted properly regarding award of coronavirus test contract. Blood Screening Market Set to Exhibit 8.1% CAGR During 2020--2030: P&S Intelligence, DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution, MeMed: DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution, Ray Dalio: Markets Won't Be as Ebullient in 2021, Via Crescentino snc ... Average Target Price: 174.58: Number Of … Qiagen Stock analysis for DiaSorin SpA (DIA:BrsaItaliana) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Disclaimer: the DIASORIN site content linked here is for United States only. Thank you for your interest. Møller - Mærsk A/S (AMKBY), Jardine Matheson (JMHLY), Henkel AG & Co. KGaA (HENKY), The Swatch Group (SWGAY), Sun Hung Kai Properties (SUHJY), Bank of Communications (BCMXY), Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY), China Shenhua Energy (CSUAY), Japan Tobacco (JAPAY), Seven & i (SVNDY) and Flutter Entertainment (PDYPY). Fundamental company data provided by Morningstar and Zacks Investment Research. Saluggia, 10340 When setting a price target estimate, an analyst is trying to … Branches include, USA, Canada, Italy, Mexico, China, India, Sweden and more. Identify stocks that meet your criteria using seven unique stock screeners. This page features the latest news about the Diasorin share. Advanced Micro Devices (NASDAQ: AMD) Stock Hasn’t Priced In Bitcoin (BTC) Fueled GPU Demand . View real-time stock prices and stock quotes for a full financial overview. Is 3M (NYSE: MMM) Earnings Beat the Start of a New Rally? Continue to our. To see all exchange delays and terms of use please see disclaimer. Mean consensus. Diasorin, analisi tecnica e target price per il trading. Price targets can be assigned to all types of securities, from complex investment products to otc stocks such as Diasorin SRL and even bonds. Penetration of the Physician Office Labs’ segment, leveraging on the LIAISON XS, with launch scheduled in 2020; LIAISON XS. BRIEF-DiaSorin's COVID-19 Test Receives Approval From Health Canada By Reuters - May 18, 2020. Vote “Underperform” if you believe DSRLF will underperform the S&P 500 over the long term. DiaSorin ITALY \ Diagnostics Upgrade BUY (Prev. DiaSorin has been working on employee engagement and retention the past few years and it shows. The company sells its products directly, as well as through an international network of independent distributors. Get DiaSorin SpA historical price data for DIAS stock. Shares in DiaSorin SpA are currently priced at €165. It's still somewhat unclear how to move … The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . One of our specialists will be in contact with you soon. Cons. Zacks Investment Research currently has $210.00 target price on the stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change. Imprese di Vercelli 13144290155 DiaSorin Molecular LLC, a division of DiaSorin S.p.A., has received the Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. It also provides various immunodiagnostic platforms, including LIAISON XL, LIAISON XS, LIAISON QuantiFERON TB Gold PLUS, LIAISON Elastase-1, and LIAISON MDX. 11. Access detailed information about the DiaSorin SpA (DIAS) Share including Price, Charts, Technical Analysis, Historical data, Diasorin Reports and more. Nella tabella sottostante sono indicate le quotazioni minime, medie e massime che un’azione Diasorin può raggiungere nel medio periodo. The stock has a market capitalization of $11.25 billion, a P/E ratio of 55.99 and a beta of 0.60. DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. DiaSorin Molecular’s Simplexa™ COVID-19 Direct Molecular Test CE Marked for Saliva Specimens. Based on analysts offering 12 month price targets for DSRLF in the last 3 months. Find the latest DIASORIN (DIA.MI) stock quote, history, news and other vital information to help you with your stock trading and investing. Note the wide gap in analyst price targets? Average target price: 166,05 € Last Close Price: 162,60 € Spread / Highest target: 23,9%: Spread / Average Target: 2,12%: Spread / Lowest Target-46,5% Receive a free world-class investing education from MarketBeat. This price target is based on 6 analysts offering 12 month price targets for DiaSorin in the last 3 months. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This page features the latest news about the Diasorin share. Latest rating agency opinion on Diasorin shares. DiaSorin S.p.A. analyst ratings, historical stock prices, earnings estimates & actuals. Morgan Stanley assumed coverage on shares of DiaSorin (OTCMKTS:DSRLF) in a report published on Wednesday, The Fly reports. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change. To date, there is limited comparison data for these different testing platforms. Chemiluminescence Immunoassay Market Size Worth $10.8 Billion By 2027: Grand View Research, Inc. To date, there is limited comparison data for these different testing platforms. Physician Office Labs. Intended Use: For the quantitative determination of C-Peptide in human serum: Material provided: Reagent integral for 100 determinations: Method: Sandwich chemiluminescent immunoassay using coated magnetic particles 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155 ), DiaSorin has received 102 “underperform” votes. Get today's DiaSorin SpA stock price and latest DIAS news as well as Diasorin real-time stock quotes, technical analysis, full financials and more. © American Consumer News, LLC dba MarketBeat® 2010-2021. Use … 30) Risk: Medium STOCK DATA Price € 28.8 Bloomberg code DIA IM Market Cap. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. This implies to us that there is a fairly broad range of possible scenarios for the underlying business. DiaSorin's management team includes the following people: Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Berenberg Bank reissued a hold rating on shares of DiaSorin in a research report on […] Fusion Fuel Green Limited (NASDAQ: HTOO) Stock is a Newly Minted Green Hydrogen Play . News. DSRLF updated stock price target summary. DiaSorin S.p.A. analyst estimates, including DSRLF earnings per share estimates and analyst recommendations. Qiagen . Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. If you would like to receive more information, including pricing information or a formal quote, please complete the form below and a … 20/03/2020. (€ mn) 1,608 Free Float 47% Shares Out. Zacks Investment Research raised DiaSorin from a hold rating to a strong-buy rating and set a $210.00 […] Looking for new stock ideas? Several other research analysts also recently issued reports on the stock. Simplexa™ molecular products, designed for use on the LIAISON ® MDX, provide reliable, clinically validated, real-time PCR products for quantitative, qualitative and multi-analyte detection. Learn about financial terms, types of investments, trading strategies and more. has the lowest price target set, forecasting a price of $10,000,000.00 for DiaSorin in the next year. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and one has issued a strong […] In the past three months, DiaSorin insiders have not sold or bought any company stock. Diasorin S.p.A. P.IVA 13144290155 Capitale sociale 55.855.439 Euro R.E.A. Earnings and Valuation. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. FREE stock and cryptocurrency quotes, message boards, fundamentals. DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. Quotazione DIASORIN (ISIN IT0003492391): prezzi aggiornati, grafici, dati fondamentali, raccomandazioni e tutte le ultime notizie sul titolo DIASORIN At that level they are trading at 6.08% premium to the analyst consensus target price of 0.00. Number of Analysts. 2002. Last Close Price. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. View DSRLF's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Multiple laboratory-developed tests (LDTs) and commercially available assays have emerged to meet diagnostic needs related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Sign-up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter. 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last twelve months. DiaSorin has a P/B Ratio of 12.76. Some companies that are related to DiaSorin include Vestas Wind Systems A/S (VWDRY), DENSO (DNZOY), ITOCHU (ITOCY), SMC (SMCAY), A.P. Touch device users, explore by touch or with swipe gestures. Bayer Aktiengesellschaft (BAYN.F) has a consensus target price of €71.19, indicating a potential upside of 34.72%. The consensus among Wall Street equities research analysts is that investors should "hold" DiaSorin stock. Zacks Investment Research upgraded shares of DiaSorin (OTCMKTS:DSRLF) from a hold rating to a strong-buy rating in a research note published on Tuesday morning, Zacks.com reports. 173,70 €. DiaSorin employs 1,971 workers across the globe. DiaSorin S.p.A.-Share Capital € 55.948.257 R.E.A. ... 1y target est: 84.14: All. Note the wide gap in analyst price targets? NetEase … I prossimi target tecnici (Add your “underperform” vote.). MOLECULAR TEST. 06/02/2020. The P/E ratio of DiaSorin is 60.39, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.84. You can opt out at any time. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Shares in DiaSorin SpA are currently priced at €173.5. MARCH 2020. Buy. 0 Wall Street analysts have set twelve-month price targets for DiaSorin in the last year. View which stocks have been most impacted by COVID-19. The company offers testing kits for infectious diseases, such as gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. A rapid and accurate test to be run on the LIAISON MDX platform to detect COVID-19 in less than 60 minutes. Do Not Sell My Information. The most optimistic DiaSorin analyst has a price target of €193 per share, while the most pessimistic values it at €89.60. Zacks Investment Research raised DiaSorin from a hold rating to a strong-buy rating and set a $210.00 price objective on the stock in a research note on Tuesday, November 17th. 157,60 TM: 101,00 TB: 201,40 TA: Qui osserviamo Target Price Medio, Basso e Alto del titolo Diasorin – MEDIO PERIODO. Fiscale e Iscrizione Reg. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.